E. Smith

Juvenile-onset systemic lupus erythematosus in the treat-to-target era: recent advances in outcome assessment

Juvenile-onset systemic lupus erythematosus (jSLE) is a rare, severe multisystem autoimmune/inflammatory disease associated with early morbidity, cumulative treatment toxicity, and long-term organ damage. In this context, outcome assessment is central to both clinical care and research, yet remains particularly chall...